封面
市場調查報告書
商品編碼
1705819

神經可塑性市場:按產品類型、按應用、按最終用戶、按地區

Neuroplasticity Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年全球神經可塑性市場規模為 111.7 億美元,到 2032 年將達到 615.3 億美元,2025 年至 2032 年的複合年成長率為 27.6%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 111.7億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 27.60% 2032年價值預測 615.3億美元
數字。 2025年神經可塑性市場佔有率(按地區)
神經可塑性市場-IMG1

神經可塑性包括多種干預措施,包括神經反饋系統、腦刺激器、認知訓練計劃和其他旨在最佳化大腦功能和促進神經可塑性變化的療法。

市場動態:

神經系統疾病盛行率的不斷上升以及對非侵入性腦刺激技術的需求不斷成長是預測期內推動全球神經可塑性市場成長的關鍵因素。

然而,預計在預測期內,缺乏認知、有限的研究和開發以及高成本將阻礙神經可塑性市場的成長。

本研究的主要特點

  • 本報告對全球神經可塑性市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模和年複合成長率(CAGR)。
  • 它還強調了各個領域的潛在商機,並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
  • 該報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數,概述了全球神經可塑性市場的主要企業。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球神經可塑性市場報告涵蓋該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員將透過用於分析全球神經可塑性市場的各種策略矩陣更輕鬆地做出決策。

目錄:

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 神經系統疾病盛行率不斷上升
    • 增加研發活動
    • 技術進步
    • 對非侵入性和個人化治療的需求不斷增加
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

第4章 全球神經可塑性市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球神經可塑性市場(依產品類型)

  • 基於軟體的解決方案
  • 基於硬體的解決方案

6. 2020 年至 2032 年全球神經可塑性市場(按應用)

  • 中風復健
  • 創傷性腦損傷 (TBI) 康復
  • 神經退化性疾病
  • 增強學習和記憶
  • 精神疾病

7. 2020 年至 2032 年全球神經可塑性市場(依最終用戶分類)

  • 醫院和診所
  • 研究機構和學術中心
  • 製藥和生物技術公司
  • 其他

8. 全球神經可塑性市場(按地區分類),2020-2032 年

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第9章 競爭態勢

  • NeuroSky Inc
  • Posit Science Corporation
  • BrainHQ
  • Synaptitude Brain Health
  • Mindmaze SA
  • NeuroVigil Inc.
  • Lumosity
  • Neuronetics, Inc
  • CogniFit
  • SharpBrains
  • Emotiv Inc
  • BrainCo
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6032

Global Neuroplasticity Market is estimated to be valued at USD 11.17 Bn in 2025 and is expected to reach USD 61.53 Bn by 2032, growing at a compound annual growth rate (CAGR) of 27.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.17 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 27.60% 2032 Value Projection: USD 61.53 Bn
Figure. Neuroplasticity Market Share (%), By Region 2025
Neuroplasticity Market - IMG1

Neuroplasticity encompasses various interventions, such as neurofeedback systems, brain stimulation devices, cognitive training programs, and other therapies designed to optimize brain function and promote neuroplastic changes.

Market Dynamics:

The increasing prevalence of neurological disorders and growing demand for non-invasive brain stimulation techniques are major factors expected to drive growth of the global neuroplasticity market during the forecast period.

However, lack of awareness, limited research and development, and high costs are expected to hamper the growth of the neuroplasticity market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global neuroplasticity market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global neuroplasticity market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include NeuroSky Inc., Posit Science Corporation, BrainHQ, Synaptitude Brain Health, Mindmaze SA, NeuroVigil Inc., Lumosity, Neuronetics, Inc., CogniFit, BrainHQ, SharpBrains, Emotiv Inc., BrainCo, Neuroscape, Neuroplast BV, Reha Technology AG, Virtualware Group, Nexeon Medsystems Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global neuroplasticity market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroplasticity market

Detailed Segmentation:

  • By Product Type:
    • Software-Based Solutions
    • Hardware-Based Solutions
  • By Application:
    • Stroke Rehabilitation
    • Traumatic Brain Injury (TBI) Rehabilitation
    • Neurodegenerative Disorders
    • Learning and Memory Enhancement
    • Mental Health Disorders
  • By End User:
    • Hospitals and Clinics
    • Research Institutes and Academic Centers
    • Pharmaceutical and Biotechnology Companies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • NeuroSky Inc.
    • Posit Science Corporation
    • BrainHQ
    • Synaptitude Brain Health
    • Mindmaze SA
    • NeuroVigil Inc.
    • Lumosity
    • Neuronetics, Inc.
    • CogniFit
    • BrainHQ
    • SharpBrains
    • Emotiv Inc.
    • BrainCo
    • Neuroscape
    • Neuroplast BV
    • Reha Technology AG
    • Virtualware Group
    • Nexeon Medsystems Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Neuroplasticity, By Product Type
    • Market Global Neuroplasticity, By Application
    • Market Global Neuroplasticity, By End User
    • Market Global Neuroplasticity, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of neurological disorders
    • Increasing research and development activities
    • Technological advancements
    • Growing demand for non-invasive and personalized treatments
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Neuroplasticity Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Neuroplasticity Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Software-Based Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Hardware-Based Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Neuroplasticity Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Stroke Rehabilitation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Traumatic Brain Injury (TBI) Rehabilitation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Neurodegenerative Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Learning and Memory Enhancement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Mental Health Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Neuroplasticity Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Research Institutes and Academic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Neuroplasticity Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • NeuroSky Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Posit Science Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BrainHQ
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Synaptitude Brain Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mindmaze SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NeuroVigil Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lumosity
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neuronetics, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CogniFit
  • SharpBrains
  • Emotiv Inc
  • BrainCo
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc
  • Analyst Views

10. Section

  • Research Methodology
  • About us